NDTDI

From WikiProjectMed
Jump to navigation Jump to search
NDTDI
Legal status
Legal status
  • Illegal in Latvia
Identifiers
  • N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide
PubChem CID
Chemical and physical data
FormulaC19H27N3O
Molar mass313.445 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23

NDTDI is a tricyclic tryptamine derivative which is thought to act as a serotonin receptor agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue of LSD and is reported to retain similar effects, though with many times lower potency. It has been sold as a designer drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.[1]

Legality

NDTDI was made illegal in Latvia in March 2017.[2]

See also

References

  1. ^ Analytical Report: NDTDI. Nacionalni Forenzični Laboratorij, Slovenia, June 2017
  2. ^ Par aizlieguma noteikšanu vielai NDTDI un tās saturošiem izstrādājumiem.
Retrieved from "https://mdwiki.org/wiki/NDTDI"